Please wait while the formulary information is being retrieved.
AMZEEQ (minocycline HCl)
- acne
4 % topical foam
- Apply to the affected area(s) by topical route once daily
Default screening record
- Apply to the affected area(s) by topical route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Clostridioides difficile infection
Severe
Moderate
- None
AMZEEQ (minocycline HCl)
- acne
- None
- Erythema
- Headache disorder
- Skin pigmentation enhancement
More Frequent
Severe
Less Severe
- None
- Abnormal desquamation
- Dry skin
- Pruritus of skin
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Contact dermatitis
Contraindicated
None
Severe Precaution
Minocycline (Topical, 4%)
Safety and effectiveness not established in patients < 9 years. Risk of permanent tooth discoloration and inhibition of bone growth before the age of 8 years.
- 1 Day – 9 Years
- Safety and effectiveness not established in patients < 9 years. Risk of permanent tooth discoloration and inhibition of bone growth before the age of 8 years.
Management or Monitoring Precaution
None
Minocycline(topical)
- Severity Level:
2
- Additional Notes: Insufficient data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Minocycline(topical)
Insufficient data available; manufacturer does not recommend
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; manufacturer does not recommend |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Acne vulgaris | |
| L70.0 | Acne vulgaris |
| 0-9 | A-Z |
|---|---|
| L70.0 | Acne vulgaris |
Formulary Reference Tool